Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


NZ research shows drug companies misleading the public

MEDIA RELEASE              December 18, 2013

The December edition of the scientific journal Acta Psychiatrica Scandinavica has published a review of studies examining the role of drug companies in the funding of mental health websites, including the first meta-analysis of studies (all conducted at the University of Auckland) comparing sites funded and not funded by drug companies.

The review identified studies of websites for six problems: Depression, Post Traumatic Stress Disorder, Anorexia, Attention Deficit Hyperactivity Disorder, Schizophrenia and Erectile Dysfunction. 152 (42%) of the 365 websites were drug company funded (including 22 actually owned by companies); with the most heavily industry-funded websites being for schizophrenia (58%).

The meta-analysis found that company funded sites are significantly biased toward biogenetic causal explanations (eg ‘chemical imbalance’ and ‘genetics’) (p < 0.01) and toward medication (p < 0.0001) compared to sites that are financially independent of the industry. For example, in 48% of the industry sponsored Erectile Dysfunction websites medication was theonly treatment mentioned, compared to 10% of websites not funded by drug companies.

Furthermore, industry funded websites for Schizophrenia were significantly more likely to perpetuate the stigmatising myths that patients become violent if they come off medication and that people with this diagnosis have little chance of recovery – by using terms such as devastating, disabling, severe, debilitating, chronic, degenerative, and long-term.

The authors, Professor John Read (ex University of Auckland, now University of Liverpool) and Amanda Cain (University of Auckland, New Zealand), concluded that “Drug company–funded websites cannot be considered an objective source of mental health information, for the public or practitioners” and that “The pervasive international influence of the pharmaceutical industry in all aspects of mental health policy, practice and research now clearly extends to the internet”.

The paper adds: “Practitioners are encouraged to inform patients about the bias inherent in industry-sponsored websites and to recommend, instead, more balanced websites that present a range of evidence-based information about causes and treatments”.
and….

“The pharmaceutical industry is using its enormous financial power to promote its products, and a
somewhat simplistic ideology about causation that provides the rationale for those products, by funding the websites of other organizations, including cash-strapped NGOs. The internet is extraordinarily hard to regulate, but very easy to influence if you have the motive and money to do so.”

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

GDP: NZ Economy Grows Faster-Than-Forecast 0.7%

New Zealand's economy grew at a faster pace than expected in the first quarter of 2016 as construction expanded at the quickest rate in two years. The kiwi dollar jumped after the data was released. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news